Debt to Equity Ratio Analysis of MoonLake Immunotherapeutics - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY Debt to Equity
Period Ending - Dec-23
Excellent Debt to Equity
0.0024
Period Ending - Dec-22
Excellent Debt to Equity
0.0031
Growth
-23.08 %
Most recent Quarter Debt to Equity
Period Ending - Mar-24
Excellent Debt to Equity
0.0024
Debt to Equity Analysis of MoonLake Immunotherapeutics
| Debt to Equity Ratio 0.0024 of MoonLake Immunotherapeutics indicates to run a business company uses lower amount of long-term debt. |
| Debt to Equity Ratio of MLTX drastically fell by -23.08 % this year. |
Other Debt to Equity Related Info of MLTX that may interest you.
MoonLake Immunotherapeutics Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| MLTX | 40.66 | 41.04 | 0.926 % | Biotechnology |
Defination of Debt to Equity Ratio
Debt to Equity Ratio shows the relationship between the company's total debt and total shareholders fund. And it indicates the ability of a company's shareholders' equity to pay its debt obligations in a tough time. more ..
Debt to Equity Related Ratios
| ShortTermDebtToEquityRatio | DividendCoverageRatio | CurrentRatio |
Tsr Stability Index
| Mild Stability | |
FY - Historical Debt to Equity Ratio of MoonLake Immunotherapeutics
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 |
|---|---|---|---|---|
| Debt to Equity | 0.0024 | 0.0031 | -1.29 | 0.0005 |
| Change | -23.08 % | 100.24 % | -249640.87 % |
FY Chart of Debt to Equity Ratio of MoonLake Immunotherapeutics
Note : All Data Generated at the End of Trading Hours (EOD Data)